Foresight and Bumhan, a Leading South Korean Bus Manufacturer, to Develop Autonomous Electric Bus Solution
December 06, 2024 08:07 ET
|
Foresight Autonomous Holdings Ltd.
Initially the parties will collaborate to develop and bring to market advanced 3D perception solutions for Bumhan’s autonomous electric buses, with plans to expand their offerings into semi- and fully...
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
December 05, 2024 18:00 ET
|
Teva Pharmaceutical Industries Ltd
Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity firm J-Will Partners Co., Ltd. ("J-Will”), through which JKI will...
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
December 05, 2024 07:13 ET
|
Purple Biotech Ltd.
REHOVOT, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that...
Teva präsentiert positive Wirksamkeits- und Sicherheitsdaten von AJOVY® (Fremanezumab) zur Vorbeugung episodischer Migräne bei Kindern und Jugendlichen aus der Phase-III-Studie SPACE
December 04, 2024 08:10 ET
|
Teva Pharmaceutical Industries Ltd
AJOVY® (Fremanezumab) reduzierte die monatlichen Migränetage (MMD) und monatlichen Kopfschmerztage (MHD) im Vergleich zu Placebo über einen Zeitraum von 12 Wochen bei pädiatrischen Patienten im Alter...
Teva présente des données positives sur l’efficacité et la sécurité d’emploi d’AJOVY® (frémanézumab) pour la prévention de la migraine épisodique chez les enfants et les adolescents dans le cadre de l’essai clinique de phase III SPACE
December 04, 2024 08:10 ET
|
Teva Pharmaceutical Industries Ltd
AJOVY® (frémanézumab) a permis de réduire de manière significative le nombre de jours de migraine mensuels (MMD, de l’anglais « monthly migraine days ») et le nombre de jours de céphalées mensuels...
Foresight Signs AI-Driven Smart Parking Solutions Collaboration Agreement with South Korean 7meerkat and KONEC
December 04, 2024 08:05 ET
|
Foresight Autonomous Holdings Ltd.
The parties will collaborate to develop and commercialize advanced AI-powered parking management solutions to enhance urban parking, making it smarter, more efficient and user-friendly Ness Ziona,...
Nayax Launches its Suite of Attended Retail Payment Solutions in Europe
December 04, 2024 07:30 ET
|
Nayax Ltd.
HERZLIYA, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by...
8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug
December 04, 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
RAMAT GAN, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial
December 04, 2024 02:00 ET
|
Teva Pharmaceutical Industries Ltd
AJOVY® (fremanezumab) significantly reduced monthly migraine days (MMD) and monthly headache days (MHD) versus placebo over a 12-week period in pediatric patients aged 6-17 years1Efficacy consistent...
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
December 03, 2024 16:05 ET
|
PennantPark Floating Rate Capital Ltd.
MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for December 2024 of $0.1025 per share, payable on...